Table 5

Estimates for clinically relevant thresholds for improvement and deterioration on the CCQ

CCQT3–T0T6–T0T12–T0Weighted threshold
 ChangeImprovementDeteriorationImprovementDeteriorationImprovementDeteriorationImprovementDeterioration
Minimal change
 Anchor-based PR (n)1073696428843291121
 Anchor-based PR−0.440.42−0.420.48−0.500.66−0.450.53
 Anchor-based RCP (n)1227143618463282
 Anchor-based RCP−0.440.46−0.380.33−0.410.39
 Distribution-based PR (n)225130181138180129586397
 Distribution-based PR−0.360.34−0.340.34−0.360.31−0.350.33
 Distribution-based RCP (n)968987807788260257
 Distribution-based RCP−0.190.19−0.260.23−0.270.20−0.240.21
Moderate change
 Anchor-based PR (n)51945737101337
 Anchor-based PR−0.86−0.721.23−0.90−0.821.23
 Anchor-based RCP (n)581295917
 Anchor-based RCP0.850.420.62
Large change
 Anchor-based PR (n)16312214342
 Anchor-based PR−0.96−1.03−1.18−1.05
 Anchor-based RCP (n)43029494
 Anchor-based RCP−1.120.98−1.120.98
No change
 Anchor-based PR (n)133115114362
 Anchor-based PR−0.070.170.100.06
 Anchor-based RCP (n)14111383337
 Anchor-based RCP−0.03−0.10−0.04−0.06
  • Data reported as clinically relevant threshold or n. Negative change represents improvement for all health status instruments. Paired t-tests were applied with significance level at p<0.05. Non-significant results were excluded, except for the ‘No change’ group.

  • CCQ, Clinical COPD Questionnaire; n, number of patients; PR, pulmonary rehabilitation; RCP, routine clinical practice; T0, baseline measurement; T3, 3-month follow-up; T6, 6-month follow-up; T12, 12-month follow-up.